|
|
Vaccine Detail
|
influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere] |
| Vaccine Information |
- Vaccine Name: influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere]
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Tradename: Fluzone Quadrivalent 2023 Southern Hemisphere
- Vaccine Ontology ID: VO_0019739
- Type: Inactivated or "killed" vaccine
- Host Species for Licensed Use: Human
|
| Host Response |
|
|
| References |
|
|
|
